Japan· JP-2359005S1356
ピコスルファートナトリウム水和物
A sodium picosulfate product containing ピコスルファートナトリウム水和物, registered in Japan by 日医工岐阜工場, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Sodium picosulfate is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AB08 (sodium picosulfate), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Sodium picosulfate · ATC A06AB08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ピコスルファートナトリウム水和物
- Manufacturer
- 日医工岐阜工場
- Country
- Japan (JP)
- ATC code
- A06AB08
- ATC class
- Sodium picosulfate
- Defined daily dose
- 5 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
516 interactions on record for sodium picosulfate.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium picosulfate · interactions on record
516 records
- 37 severe
- 475 moderate
- 4 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A06AB08
Sodium picosulfate, as other registers publish it.
- DenmarkActilaxCooper Consumer Health B.V.
- FinlandAgiopicMadaus GmbH
- United KingdomCitraFleet oral powder 15.08g sachetsRecordati Pharmaceuticals Ltd
- United KingdomCitraFleet oral powder 16.11g sachetsCasen Recordati S.L.
- United KingdomCrescent Pharma Liquid Laxative 5mg/5ml oral solutionCrescent Pharma Ltd
- GermanyDulcolax Np PerlenA. Nattermann & Cie. Gmbh
- GermanyDulcolax Np TropfenA. Nattermann & Cie. Gmbh
- United KingdomDulcolax Pico 2.5mg PerlesBoehringer Ingelheim Self-Medication Division
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdc90c3d-8d8a-446c-ba0c-f9ce4a1de39b GET /v1/drugs/bdc90c3d-8d8a-446c-ba0c-f9ce4a1de39b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．７５％１ｍＬ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2359005S1356",
"category": "内用薬",
"price_yen": 8.5,
"generic_name": "ピコスルファートナトリウム水和物",
"product_name_jp": null,
"therapeutic_class": "2359",
"transitional_expiry": null
}See everything about sodium picosulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.